Home › Funds › Vanguard Group › SGMT
Vanguard Group position in SGMT
SAGIMET BIOSCIENCES INC · Health Care
Latest position (Q4 2025)1.26M sh
Reported value held$7.46M
Portfolio Weight0.00%
First reportedQ3 2023
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 246.02K | $2.16M | New |
| Q4 2023 | 245.09K | $1.33M | Hold |
| Q1 2024 | 1.14M | $6.18M | Add |
| Q2 2024 | 1.07M | $3.67M | Reduce |
| Q3 2024 | 1.05M | $2.90M | Reduce |
| Q4 2024 | 1.13M | $5.09M | Add |
| Q1 2025 | 1.15M | $3.76M | Add |
| Q2 2025 | 1.15M | $8.79M | Hold |
| Q3 2025 | 1.20M | $8.25M | Add |
| Q4 2025 | 1.26M | $7.46M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding SGMT
- BlackRock Inc 6.58M sh · $50.83M · Q2 2026
- Balyasny Asset Management 3.63M sh · $28.03M · Q2 2026
- Geode Capital Management 1.44M sh · $11.17M · Q2 2026
- Millennium Management 937.02K sh · $7.24M · Q2 2026
- Goldman Sachs Group 759.09K sh · $5.87M · Q2 2026
- Hillhouse Capital (HHLR Advisors) 724.80K sh · $5.60M · Q2 2026
- Northern Trust Corp 468.38K sh · $3.62M · Q2 2026
- Farallon Capital Management 415.00K sh · $3.21M · Q2 2026
- Renaissance Technologies 346.93K sh · $2.68M · Q2 2026
- UBS Group AG 339.93K sh · $2.63M · Q2 2026
- Citadel Advisors 289.93K sh · $2.24M · Q2 2026